![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Bergfeldt K, Einhorn S, Rosendahl I, et al. Increased risk of second primary malignancies in patients with gynaecological cancer. A Swedish record-linkage study. Acta Oncologica 1995; 34: 771–777
- Bittorf B, Kessler H, Merkel S, et al. Multiple primary malignancies: An epidemiological and pedigree analysis of 57 patients with at least three tumours. European Journal of Surgical Oncology 2001; 27: 302–313
- Brown E, Stewart M, Rye T, et al. Carcinosarcoma of the ovary: 19 years of prospective data from a single Center. Cancer 2004; 100: 2148–2153
- Harris M A, Delap L M, Sengupta P S, et al. Carcinosarcoma of the ovary. British Journal of Cancer 2003; 88: 654–657
- Tate Thigpen J, Blessing J A, DeGeest K, et al. Cisplatin as initial chemotherapy in ovarian carcinosarcomas: a Gynecologic Oncology Group study. Gynecologic Oncology 2004; 93: 336–339, Gynecologic Oncology Group